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SHORT REPORT
Family support for stroke: one year follow up of a
randomised controlled trial
J Mant, S Winner, J Roche, D T Wade
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Background: There is evidence that family support can
benefit carers of stroke patients, but not the patients
themselves.
Objective: To extend the follow up of a single blind
randomised controlled trial of family support for stroke
patients and carers to one year to ascertain whether there
were any late effects of the intervention.
Methods: The study was a randomised controlled trial.
Patients admitted to hospital with acute stroke who had a
close carer were assigned to receive family support or
normal care. Families were visited at home by a researcher
12 months after the stroke, and a series of questionnaires
was administered to patient and carer.
Results: The benefits to carers mostly persisted, though they
were no longer statistically significant because some patients
were lost to follow up. There was no evidence of any effects
on patients.
Conclusion: Family support is effective for carers, but
different approaches need to be considered to alleviate the
psychosocial problems of stroke patients.
I
n recognition of the impact that stroke has on carers as
well as patients,1 services such as Stroke Association family
support have been developed in the United Kingdom which
provide information, emotional support, and liaison with
other services. The service maintains contact through a
combination of home and hospital visits and telephone calls.
In the Oxford family support trial, we found that this service
was associated with significantly improved quality of life of
carers at follow up six months after the stroke, but had no
effects on patients.2 Other randomised controlled trials of the
service in other areas have also found no evidence of benefit
to patients with follow up varying from four to nine months
after recruitment.3 4 The lack of benefit to patients may be
attributable to the short duration of follow up in these trials.
The service usually maintains contact with a family for a year,
and some patients spend a significant proportion of the first
six months in hospital, during which time family support
might be anticipated to have less impact. We carried out a
second follow up of participants in the Oxford trial to
investigate the effects of family support on patients and
carers one year after the stroke.
METHODS
The methods and principal results of the Oxford family
support study have been reported elsewhere.2 In brief,
patients admitted to hospital with acute stroke who had a
close family carer were randomly allocated to receive normal
care (controls) or normal care plus contact with a stroke
family support organiser (FSO). The level of contact with
each family was at the discretion of the FSO. For the one year
follow up (as at six months), the families were visited at
home by a researcher who was blinded to intervention group
status. The measures used are shown in table 1. The 12
month follow up was carried out before the results of the six
month follow up were known. If carers were not present,
questionnaires were left for self completion and return by
post.
We had estimated that 300 participants would be needed to
detect clinically relevant differences between groups with
80% power. Data were analysed using SPSS for windows
(version 10.0). The significance of differences between FSO
and control groups was assessed with the Mann–Whitney
test. To explore the characteristics of carers who dropped out
between six and 12 months, six month outcomes where there
had been significant differences between intervention and
control—the Frenchay activities index, quality of life using
the Dartmouth Coop chart, and five dimensions of the SF-36
(energy, mental health, pain, physical function, and general
health perception)—were compared in carers who did and
did not participate at 12 months. Ethics approval was granted
by the Central Oxford research ethics committee.
RESULTS
Of 520 randomised patients, 388 (75%) were still alive at 12
months. Consent was obtained after randomisation, and 50
families declined involvement,2 leaving 338 potential partici-
pants at 12 months, of whom 296 (90% of intervention group
and 86% of control group) were followed up (fig 1). Seventy
four per cent of carers in the intervention group and 69% in
the control group were followed up. In three cases (all in the
intervention group), the carer had died but in the remainder
the carer was not available when the patient was interviewed
and did not return the questionnaires left for self completion.
Between six and 12 months, the FSO visited 65 families at
home (44%), contacted 120 (81%) by telephone at least once,
and liaised with other services for 15 families (10%). She
visited only four patients in hospital. Twenty seven families
(18%) had no contact with the FSO after six months. The
average number of contacts of any sort between six and 12
months was three (as compared with five in the first six
months). Patients in the intervention group who were
followed up had significantly more contact with the FSO,
with a mean total number of contacts of 7.8 (n=148) over
the twelve months, as compared to 5.1 (n=45) contacts in
those not followed up (p,0.001).
Carer outcomes (table 1) were similar to those obtained at
six month follow up2 in that all but two of the differences
were in favour of the intervention, and of the same order of
magnitude with two exceptions. For both the Frenchay
activities index and the mental health component of the SF-
36, the differences observed at 12 months was smaller than
those seen at six months. Patient outcomes (table 1) were
Abbreviations: FSO, family support organiser; SF-36, short form 36
item health assessment questionnaire
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also similar to those obtained at the six month follow up:
some differences favoured the FSO group and some the
control group. None of the differences was statistically
significant.
For six of the seven measures tested, carers who were
followed up at both six and 12 months had better mean
outcomes at six months than carers who were only followed
up at six months. For one of these measures (SF-36 general
health perception), the difference was statistically significant
(72.2 v 63.6, p=0.02).
DISCUSSION
We found no evidence of benefit to stroke patients from a
family support service at one year. In contrast to our earlier
report,2 we also found no significant benefits to carers at one
year. Nevertheless, the 12 month carer outcomes were
broadly similar to the six month outcomes. Fifty five fewer
carers were followed up at 12 months than at six months, so
the likeliest explanation for the non-significant results for
carers at 12 months is loss of statistical power. This will have
been exacerbated by differential loss to follow up of carers
with worse outcomes at six months. In contrast, adequate
power was maintained to detect any important differences
affecting patients at one year. Within the intervention group,
Table 1 Carer and patient outcomes one year after stroke
Outcome measures
Median (IQR) scores Difference
between
scores*
Range of scale
(bad–good)
Number of
complete responses
p ValueFS C FS C
Carers
Frenchay activities index 32 (28 to 35) 32 (28 to 36) 0.0 0 to 45 103 96 0.97
GHQ-28 17 (10 to 24) 17 (13 to 23) +0.3 84 to 0 93 90 0.38
Caregiver strain index 4 (1 to 6) 3 (1 to 6) 20.3 13 to 0 107 100 0.37
SF-36 0 to 100
Change in health 50 (25 to 50) 50 (25 to 50) 23.2 106 101 0.18
Energy and vitality 55 (35 to 70) 55 (35 to 60) +5.2 103 93 0.05
Mental health 76 (64 to 88) 72 (60 to 84) +1.7 101 95 0.25
Pain 88.9 (55.6 to 100) 72.2 (55.6 to 100) +5.7 108 98 0.08
Physical function 90 (70 to 100) 80 (65 to 95) +4.9 103 94 0.08
Role limitation (emotional) 100 (100 to 100) 100 (66.7 to 100) +1.9 106 95 0.65
Role limitation (physical) 100 (75 to 100) 100 (50 to 100) +7.8 106 95 0.23
Social function 100 (88.9 to 100) 100 (77.8 to 100) +3.2 98 87 0.51
General health perception 82 (61.5 to 87) 72 (54.2 to 87) +5.3 105 93 0.07
Dartmouth co-op chart 5 to 1
Physical fitness 3 (2 to 4) 3 (2 to 4) +0.2 91 83 0.38
Feelings 2 (1 to 3) 2 (1 to 3) +0.2 90 81 0.19
Daily activities 1 (1 to 2) 1 (1 to 3) +0.3 91 82 0.06
Social activities 1 (1 to 1) 1 (1 to 2) +0.2 89 83 0.14
Pain 3 (1 to 4) 3 (1 to 4) +0.2 89 83 0.36
Change in health 3 (3 to 3) 3 (3 to 3) +0.2 92 81 0.09
Overall health 3 (2 to 3) 3 (2 to 4) +0.1 92 83 0.54
Social support 1 (1 to 3) 1 (1 to 3) +0.2 91 84 0.48
Quality of life 2 (2 to 3) 2 (2 to 3) +0.2 90 82 0.19
Patients
Barthel index 17 (13 to 19) 18 (15 to 20) 21.0 0 to 20 146 148 0.06
Rivermead mobility index 9 (4 to 13.75) 11 (7 to 13) 21.0 144 146 0.17
Frenchay activities index 13.5 (6 to 28) 15.5 (6 to 25) +0.2 142 138 0.92
London handicap scale 63.4 (54.6 to 75.3) 63.4 (55.1 to 74.1) +0.5 135 144 0.98
HADS 21 to 0
Anxiety 4 (2 to 7) 4 (2 to 7) 20.3 119 118 0.58
Depression 5 (3 to 7) 5 (3 to 7) 20.2 115 109 0.51
Dartmouth co-op chart
Physical fitness 5 (4 to 5) 5 (4 to 5) 0 5 to 1 145 146 0.92
Feelings 2 (1 to 3) 2 (1 to 3) 20.1 142 145 0.32
Daily activities 3 (2 to 4) 3 (2 to 4) 0 143 146 0.88
Social activities 2.5 (1 to 4) 3 (1 to 4) +0.1 142 145 0.48
Pain 3 (1 to 4) 3 (1 to 4) 20.2 145 145 0.36
Change in health 3 (3 to 3) 3 (3 to 3) 0 141 146 0.79
Overall health 3 (3 to 4) 3 (3 to 4) +0.1 141 146 0.59
Social support 1 (1 to 1) 1 (1 to 2) +0.1 140 147 0.33
Quality of life 2 (2 to 3) 2 (1 to 3) 0 139 146 0.47
*Difference between mean family support and mean control scores; positive difference in means always favours intervention.
C, control; FS, family support; GHQ-28, 28 item version of the general health questionnaire; HADS, hospital anxiety and depression scale; IQR, interquartile
range; SF-36, 36 item short form health assessment questionnaire.
Randomised
520
Died: 67
Declined to take part: 22
Lost to follow up: 25
Died: 65
Declined to take part: 28
Lost to follow up: 17
Patient follow up
at 12 months
146
(includes 9 not followed up
at 6 months)
Patient follow up
at 12 months
148
(includes 5 not followed
up at 6 months)
Family support
258
Control
262
Carer follow up
110 (74%)
Carer follow up
102 (69%)
Figure 1 Patient flows through the study.
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patients with greater contact with the FSO were more likely
to be followed up. The impact of this on the results is difficult
to predict. On the one hand, families with more contact with
the FSO tended to have worse outcomes,2 but on the other
hand, they will have been more likely to have derived benefit.
The negative result of this study is consistent with another
trial of a related intervention—specialist nurse support—
which followed up stroke patients for one year.5 While family
support is effective for carers, different approaches such as
formal training of carers6 need to be considered to address the
psychosocial problems of stroke patients.
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